ArticleFrontiers in endocrinology2026

Repurposing a prostate tumor marker: elevated FPSA/TPSA ratio as a novel non-invasive biomarker for declining eGFR in male type 2 diabetes.

Shihua Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.